日本の内視鏡治療機器市場（2024年～2031年）

日本の内視鏡治療機器の市場規模は、2023年に27億米ドルに達し、2031年には44億4,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは6.4%で成長する見込みです。

内視鏡検査機器は、内臓や構造を可視化して検査するために使用される医療機器で、低侵襲の診断や治療を可能にします。消化器内科、呼吸器内科、婦人科、整形外科などの分野で極めて重要であり、大腸内視鏡検査、気管支内視鏡検査、腹腔鏡検査などの処置を容易にします。高解像度や3D可視化などの画像技術の進歩は、正確さと精度を高め、侵襲的な手術の必要性を減らし、患者の早期回復を促進します。

市場力学：

促進要因と抑制要因

内視鏡検査機器の技術進歩

内視鏡検査機器市場は、高精細画像、3D可視化、AI支援診断などの技術進歩により成長しています。これらの技術は、内視鏡処置の精度と効率を向上させ、医師がより正確に異常を検出できるようにします。AIを搭載したアルゴリズムはリアルタイムの画像解析を強化し、がんやポリープなどの状態を示すパターンを特定します。カプセル内視鏡は、消化管診断においてより患者に優しいアプローチを提供します。柔軟なロボット内視鏡は、複雑な処置における操作性とアクセス性を改善し、組織外傷と回復時間を最小限に抑えます。

例えば、2024年10月、オリンパス株式会社は、ハードウェア、ソフトウェア、サービス、データを統合し、臨床上の意思決定と業務効率を改善する包括的な医療技術システムである「インテリジェント内視鏡エコシステム」を発表しました。

「インテリジェント内視鏡エコシステム」は、シームレスなコミュニケーションとインテリジェントなコンポーネントに焦点を当てた、内視鏡検査の未来像です。このシステムは、AIアルゴリズムを使用して患者の転帰と業務効率を改善し、病院と内視鏡室の医師に利益をもたらします。臨床現場で生成されるデータと、さまざまなソフトウェアの適用により、システムの機能が強化されます。

高いコストと限られたアクセシビリティ

内視鏡検査機器や処置は、特に中低所得国の多くのヘルスケア施設にとって手の届かない高額なコストのため、大きな市場抑制要因に直面しています。また、メンテナンスや修理にかかる費用も経済的負担に拍車をかけており、資源に乏しい環境での導入は制限されています。このような高度な機器を操作する熟練した専門家の不足が、特に農村部や十分なサービスを受けていない地域での問題をさらに複雑にしています。このような格差は診断や治療の遅れにつながり、患者の転帰に悪影響を及ぼします。費用対効果の高い解決策を開発し、ヘルスケア専門家を育成する努力にもかかわらず、こうした課題は依然として残っています。

例えば、基本的な内視鏡システム、バイポーラ鉗子本体システム、高速ドリル本体システムの初期費用は、ビデオ機器を除いて、それぞれ450万円、350万円、303万5,000円です。費用対効果が高く、患者中心の臨床結果が得られるにもかかわらず、ビデオ機器や互換性のあるビデオ機器が必要であるにもかかわらず、FELDを適切に提供するために病院経営は苦慮しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 内視鏡検査機器の技術的進歩
• 抑制要因
  • 高額な費用とアクセスの制限
• 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 内視鏡
• 内視鏡手術装置
• 内視鏡可視化装置

第7章 用途別

• 婦人科内視鏡検査
• 消化管内視鏡検査
• 気管支鏡検査
• 泌尿器科内視鏡検査
• 関節鏡検査
• 腹腔鏡検査

第8章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 専門クリニック

第9章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第10章 企業プロファイル

• Olympus Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• HOYA Corporation（Pentax Medical）
• Fujifilm Holdings Corporation
• Sumitomo Bakelite Co., Ltd.
• Shinko Optical Co., Ltd.
• TOP Corporation
• KARL STORZ Japan K.K.
• Nipro Corporation
• Terumo Corporation
• Hitachi Ltd

第13章 付録

The Japan Endotherapy Devices market reached US$ 2.70 billion in 2023 and is expected to reach US$ 4.44 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.

Endoscopy devices are medical instruments used to visualize and examine internal organs and structures, enabling minimally invasive diagnosis and treatment. They are crucial in fields like gastroenterology, pulmonology, gynecology, and orthopedics, facilitating procedures like colonoscopy, bronchoscopy, and laparoscopy. Advancements in imaging technologies, such as high-definition and 3D visualization, enhance accuracy and precision, reducing the need for invasive surgeries and promoting faster patient recovery.

Market Dynamics: Drivers & Restraints

Technological Advancements in Endoscopy Devices

The endoscopy devices market is growing due to technological advancements like high-definition imaging, 3D visualization, and AI-assisted diagnostics. These technologies improve the precision and efficiency of endoscopic procedures, enabling physicians to detect abnormalities more accurately. AI-powered algorithms enhance real-time image analysis, identifying patterns indicative of conditions like cancer or polyps. Capsule endoscopy offers a more patient-friendly approach to gastrointestinal diagnostics. Flexible robotic endoscopes improve maneuverability and accessibility in complex procedures, minimizing tissue trauma and recovery time.

For instance, in October 2024, Olympus Corporation introduced the Intelligent Endoscopy Ecosystem, a comprehensive medical technology system that integrates hardware, software, services, and data to improve clinical decision-making and operational efficiency.

The "Intelligent Endoscopy Ecosystem" is a vision for the future of endoscopy, focusing on seamless communication and intelligent components. This system uses AI algorithms to improve patient outcomes and operational efficiencies, benefiting hospitals and doctors in the endosuite. Data generated in clinical settings and the application of different software will enhance the system's capabilities.

High Costs and Limited Accessibility

Endoscopy devices and procedures face significant market restraint due to their high costs, which make them unaffordable for many healthcare facilities, especially in low- and middle-income countries. Maintenance and repair expenses also add to the financial burden, limiting their adoption in resource-constrained settings. The lack of skilled professionals to operate these sophisticated devices further complicates the issue, particularly in rural and underserved areas. This disparity results in delayed diagnoses and treatments, negatively impacting patient outcomes. Despite efforts to develop cost-effective solutions and train healthcare professionals, these challenges persist.

For instance, The initial costs for basic endoscope systems, bipolar forceps main body systems, and high-speed drill main body systems are ¥4,500,000, ¥3,500,000, and ¥3,035,000, respectively, excluding video equipment. Despite the high cost-effectiveness and patient-centered clinical outcomes, hospital management struggles to provide FELD appropriately, despite the need for video equipment and compatible video equipment.

Segment Analysis

The Japan endotherapy devices market is segmented based on product type, application and end user.

Product Type:

Endoscopes segment is expected to dominate the endotherapy devices market share

The endoscopes segment holds a major portion of the endotherapy devices market share and is expected to continue to hold a significant portion of the endotherapy devices market share during the forecast period.

Japan's endotherapy devices market is dominated by endoscopes, which are essential for minimally invasive medical procedures. With an aging population and increasing prevalence of gastrointestinal and chronic diseases, Japan has seen a surge in demand for endoscopic interventions. Endoscopes enable precise visualization and access to internal organs for diagnostic and therapeutic purposes, and are widely used in procedures like polypectomy, hemostasis, and stent placements. Japan's robust healthcare infrastructure and focus on preventive care have fueled the adoption of advanced endoscopic technologies, solidifying their crucial role in the nation's endotherapy devices landscape.

Moreover, novel product launches also help the segment to grow during the forecast period, for instance, in October 2024, Olympus has launched two bronchoscopes as part of its EVIS X1 Endoscopy System, which offers the latest in diagnostic and therapeutic bronchoscopy. The bronchoscopes feature slim outer diameters and large working channels, offering access to more distal airways. They are designed with high-definition imaging, allowing for improved suction and flexibility during procedures. The system also allows for the passage of a wide array of diagnostic and therapeutic devices through large working channels, providing physicians with options to successfully address the tracheal bronchial tree.

Gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share

The gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

Gynecology endoscopy is a key component in Japan's endotherapy devices market, focusing on advanced healthcare solutions for women's health. This minimally invasive technique is used for diagnosing and treating gynecological conditions like endometriosis, uterine fibroids, ovarian cysts, and infertility-related issues. With growing awareness of reproductive health and demand for early diagnosis, gynecological endoscopic procedures like hysteroscopy and laparoscopy have gained popularity. These procedures offer reduced pain, shorter recovery times, and minimal scarring, catering to Japan's aging and health-conscious population.

For instance, in September 2024, Olympus Corporation has launched a new 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Europe. The head is compatible with the VISERA ELITE III video system center for surgical endoscopy. The product will be launched in Japan, Hong Kong, and Singapore in September 2024, following regulatory compliance. The technical development was led by Sony Olympus Medical Solutions Corporation, a joint venture between Olympus and Sony Corporation.

Competitive Landscape

The major Japan players in the endotherapy devices market include Olympus Corporation, HOYA Corporation (Pentax Medical), Fujifilm Holdings Corporation, Sumitomo Bakelite Co., Ltd., Shinko Optical Co., Ltd, TOP Corporation, KARL STORZ Japan K.K., Nipro Corporation, Terumo Corporation, Hitachi Ltd. among others.

Emerging Players

The emerging players in the endotherapy devices market include JMS Co., Ltd, Matsunami Glass Ind., Ltd, Asahi Intecc Co., Ltd, Nissha Medical Technologies, Kuraray Co., Ltd, Sysmex Corporation among others.

Key Developments

• In October 2023, Olympus has introduced its next-generation EVIS X1 endoscopy system for gastrointestinal practitioners, along with GIF-1100 and CF-HQ1100DL/I compatible endoscopes. The GIF-1100 is for the upper digestive tract, while the CF-HQ1100DL/I is for the lower digestive tract. The system received approval earlier this year.
• In November 2023, Olympus Corporation has launched its next-generation EVIS X1 endoscopy system in China, marking its availability in all of Olympus' major markets. The advanced system, first released in Europe, Japan, and the U.S. in April 2020, has now received clearance in China, marking its first launch in China since its launch in Europe, Japan, and the U.S. in October 2023.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan endotherapy devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Technological Advancements in Endoscopy Devices
• 4.2. Restraints
  • 4.2.1. High Costs and Limited Accessibility
• 4.3. Opportunity
  • 4.3.1. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Endoscopes *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Endoscopic Operative Devices
• 6.4. Endoscopic Visualization Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Gynecology Endoscopy*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Gastrointestinal (GI) Endoscopy
• 7.4. Bronchoscopy
• 7.5. Urology Endoscopy
• 7.6. Arthroscopy
• 7.7. Laparoscopy

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers (ASCs)
• 8.4. Specialty Clinics

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

• 10.1. Olympus Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio and Description
  • 10.1.3. Financial Overview
  • 10.1.4. Key Developments
• 10.2. HOYA Corporation (Pentax Medical)
• 10.3. Fujifilm Holdings Corporation
• 10.4. Sumitomo Bakelite Co., Ltd.
• 10.5. Shinko Optical Co., Ltd.
• 10.6. TOP Corporation
• 10.7. KARL STORZ Japan K.K.
• 10.8. Nipro Corporation
• 10.9. Terumo Corporation
• 10.10. Hitachi Ltd

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1 About Us and Services
• 13.2 Contact Us